3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
2
Uterine Cervical Dysplasia
2
Thyroid Nodule
2
Sarcoma
2
Prostatic Neoplasms
2
Melanoma
2
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Spinal Cord Compression
1
Precancerous Conditions
1
Papillomavirus Infections
1
Neoplasms, Unknown Primary
1
Neoplasms by Site
1
Neoplasms
1
Hyperthyroidism
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Gastrointestinal Neoplasms
1
Female Urogenital Diseases and Pregnancy Complications
1
Colorectal Cancer Metastatic
1
Carcinoma, Renal Cell
1
Breast Neoplasms
1
Adenocarcinoma
1
Acquired Immunodeficiency Syndrome
1
Interventions
relatlimab
1
pembrolizumab
1
enfortumab vedotin
1
darolutamide
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Radiotherapy
1
Radiation Dose Hypofractionation
1
Pregnancy Tests
1
Nivolumab
1
Mitomycin
1
Human Papillomavirus DNA Tests
1
Gemcitabine
1
Fluorouracil
1
Colposcopy
1
Cisplatin
1
Biopsy
1
Acetic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Urogenital Diseases
×
Transurethral Resection of Prostate
×
1 year
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled